Patents by Inventor Emma Stanley

Emma Stanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SERUM ALBUMIN-BINDING POLYPEPTIDES
    Publication number: 20230272011
    Abstract: Provided herein, in some embodiments, are recombinantly engineered variant of stefin polypeptides (AFFIMER® polypeptides) that binds to human serum albumin and extends the half-life of the polypeptides. Also provided herein, in some embodiments, are composition containing the polypeptides, methods of using the polypeptides, and methods of producing the polypeptides.
    Type: Application
    Filed: July 30, 2021
    Publication date: August 31, 2023
    Applicant: Avacta Life Sciences Limited
    Inventors: Emma Jenkins, Estelle Adam, Emma Stanley, Amrik Basran, Matthew P. Vincent, Bruno Gomes
  • SERUM HALF-LIFE EXTENDED PD-L1 INHIBITORY POLYPEPTIDES
    Publication number: 20230272081
    Abstract: Provided herein, in some embodiments, are fusion proteins comprising recombinantly engineered variant of stefin polypeptide (an AFFIMER® polypeptide) that binds to PD-L1 and a polypeptide that binds to human serum albumin (HSA). Also provided herein, in some embodiments, are compositions containing the fusion proteins, methods of using the fusion proteins, and methods of producing the fusion proteins.
    Type: Application
    Filed: July 30, 2021
    Publication date: August 31, 2023
    Applicant: Avacta Life Sciences Limited
    Inventors: Emma Jenkins, Estelle Adam, Emma Stanley, Amrik Basran, Matthew P. Vincent
  • PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO
    Publication number: 20210163599
    Abstract: The present disclosure relates to proteins including PD-L1 binding affimer polypeptide sequences, gene expression constructs encoded those proteins, cells expressing those proteins, and pharmaceutical preparations of those proteins, gene expression constructs and cells and use in the treatment of various human conditions including cancer.
    Type: Application
    Filed: April 11, 2019
    Publication date: June 3, 2021
    Applicant: Avacta Life Sciences Limited
    Inventors: Amrik Basran, Emma Jenkins, Estelle Adam, Michelle Writer, Emma Stanley